A new report has recommended greater caution and strict monitoring of the prescribing of benzodiazepines and other drugs.
The report aims to reduce the overprescribing of sleeping pills to people.
The report, 'Examining the overprescribing of Benzodiazepines, Z Drugs and Gabapentinoids in Ireland', was produced by a multi-agency working group, led by the Medical Council.
Dr Margaret O' Riordan, chairperson of the working group, said that while benzodiazepines may have a role in the treatment of a patient on a time-limited basis, caution and strict monitoring are required when they are prescribed.
She said the overprescribing of these drugs is an issue that affects patient safety and has significant implications for public health.
The working group was set up following an increase in serious complaints relating to the overprescribing of benzodiazepines.
HSE National Clinical Lead for Addiction Services Professor Eamon Keenan said that benzodiazepines were the fourth most common drug causing presentations to addiction services in 2023, accounting for 1,477 cases.
He said that these drugs are also implicated in drug-related deaths.
We need your consent to load this rte-player contentWe use rte-player to manage extra content that can set cookies on your device and collect data about your activity. Please review their details and accept them to load the content.Manage Preferences
There has been a 45% increase where benzodiazepines have been implicated over the years from 2012 to 2021, Prof Keenan said.
Deaths where pregabalin has been implicated have risen from 14 in 2013 to 83 in 2021.
The report calls for the further education of doctors, pharmacists and the public on the issue.
It also recommends a central repository for data, accessible to prescribers, to enhance visibility of private prescribing of controlled drugs.
Benzodiazepines, like diazepam and alprazolam, are a class of drugs known as sedatives.
Z-drugs, like zolpidem, are a newer class of drugs used to treat insomnia.
Gabapentinoids like pregabalin, are antiepileptic drugs which are also used to calm nerve signals and for chronic pain.
The report says consideration should be given to including pregablin and gabapentin on the Controlled Drugs List.
